Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03983499 · ClinicalTrials.gov registry record · NA

Latinos Understanding the Need for Adherence in Diabetes

A NA study of Type 2 Diabetes and Psychological Distress, sponsored by San Diego State University.

Completed
Registry status
NA
Development phase
456
Enrollment target
1
Study location

NCT03983499: Completed NA study of Type 2 Diabetes and Psychological Distress, sponsored by San Diego State University.

NCT03983499 is a NA study of Type 2 Diabetes and Psychological Distress that has completed, run by San Diego State University. The registered enrollment target is 456 participants, below the 3,922-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03983499, a NA study of Type 2 Diabetes and Psychological Distress, has completed, sponsored by San Diego State University.

COMPLETED
Registry status
NA
Development phase
456 participants
Enrollment target
1
Study location

Study Summary

The Latinos Understanding the Need for Adherence in Diabetes (LUNA-D) study, is a randomized controlled trial testing the effectiveness of an integrated behavioral health and primary care chronic care disease management intervention for low income Latino patients with type-2 diabetes mellitus (T2DM) that have 2 or more chronic health conditions. LUNA-D focuses on diabetes management and behavioral health care integration.

Primary Outcome

The primary outcome is change in HbA1c values among non-insulin using type 2 diabetes mellitus Latino patients through a linguistically and culturally appropriate evidence-based application of a Chronic Care Model (LUNA-D).

Interventions

  • BEHAVIORAL Special Intervention

Study Locations (1)

California

  • South Bay Latino Research Center - Chula Vista

Trial Details

FieldValue
Enrollment Target 456 participants
Start Date 2015-07-16
Est. Completion 2018-12-31
Phase NA
San Diego State University

118 total trials

What the finished NCT03983499 record still lists

NCT03983499 is an interventional study that assigns participants to a tested intervention. The registered 456 participants enrollment target is mid-sized for trials with a published cap, below the 3,922-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (88% lower).

The record links to 4 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Special Intervention is the first listed.

NCT03983499 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03983499 about?

NCT03983499 is a clinical study titled "Latinos Understanding the Need for Adherence in Diabetes". The Latinos Understanding the Need for Adherence in Diabetes (LUNA-D) study, is a randomized controlled trial testing the effectiveness of an integrated behavioral health and primary care chronic care disease management intervention for low income Latino patients with type-2 diabetes mellitus (T2DM)...

What is the current status of trial NCT03983499?

This trial is currently completed. It is a NA study. The enrollment target is 456 participants. The study started on 2015-07-16. Estimated completion is 2018-12-31.

What conditions does trial NCT03983499 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Psychological Distress, Cardiovascular Risk Factors, Glycemic Control.

What interventions are being tested in trial NCT03983499?

The interventions under investigation include: Special Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03983499?

This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03983499 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03983499's enrollment target sits among peer trials

456 47th of 327 higher than 281 of 327 other Type 2 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04462302 · 456 participants · NA

    An Internet-based Program to Help Cancer Survivors Manage Pain

  • NCT05820919 · 456 participants · NA

    Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

  • NCT06254612 · 456 participants · Phase 2

    A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

  • NCT06457841 · 456 participants · NA

    Stress and Resilience

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03983499, the US trial registry maintained by the National Library of Medicine. NCT03983499 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.